NOVEL NUCLEOSIDES AS ANTICANCER AND ANTIVIRAL AGENTS
NOVEL NUCLEOSIDES AS ANTICANCER AND ANTIVIRAL AGENTS
批准号:
3188510
负责人:
TAI-SHUN LIN
金额:
$13.8万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1987
资助国家:
美国
项目状态:
已结题
起止时间:
1987-08-01 至 1990-07-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This investigation has as its goal the design and synthesis of a
series of potential anticancer and antiviral nucleoside analogues,
the evaluation of their biological activities both in vitro and in
vivo in tumor-bearing and virus infected animals, and the
elucidation of the biochemical mechanism of action(s) of their
biological activity. The approaches to be employed include the
development of methodology for the preparation of these
nucleoside analogues, their characterization by NMR, UV, mass
spectrum, and other spectrometric techniques, and the
determination of their anticancer and antiviral activities in cell
culture and in animal models.
Recently, the synthesis and antineoplastic evaluation of several
new 3'-azido and 3'-amino nucleoside analogues have been carried
out in this laboratory. Among these compounds, 3'-amino-2',
3'dideoxycytidine (3'-NH2-CdR, NSC 365107) has shown potent
inhibitory effects against L1210, P388 and Sarcoma 180 cells in
vitro. The cytotoxicity was selectively prevented by 2'-
deoxycytidine, and not by other pyrimidine deoxyribo- or
ribonucleosides, or purine nucleosides. More importantly, the 3'-
amino analogue of 2'-deoxycytidine exhibits marked anticancer
activity against both L1210 and P388 leukemias in mice. Thus
when given in a dose of 20 mg/Kg twice a day for nine
consecutive days to animals bearing the L1210 leukemia, 3'-NH2-
CdR produced cures in 80% of the treated animals, and this
regimen yielded a T/C X 100 value of 200 in mice bearing the
P388 leukemia. 3'-NH2-CdR is resistant to deamination by
purified cytidine-deoxycytidine deaminase derived from human
KB cells; both cytidine and 2'-deoxycytidine are readily
deaminated by this enzyme system. Based on these findings, the
fabrication and chemotherapeutic testing of a novel series of
nucleoside analogues are proposed in which the sugar portion is
modified and the base moeity varied. The molecular basis for the
activity of those compounds that are biologically active will be
determined.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
3'-DEOXYNUCLEOSIDE ANALOGS AS POTENTIAL ANTIVIRAL AGENTS
-
批准号:3144251
-
项目类别:
-
资助金额:$12.54万
-
财政年份:1990
-
负责人:TAI-SHUN LIN
-
依托单位:
3'-DEOXYNUCLEOSIDE ANALOGS AS POTENTIAL ANTIVIRAL AGENTS
-
批准号:3144252
-
项目类别:
-
资助金额:$13.05万
-
财政年份:1990
-
负责人:TAI-SHUN LIN
-
依托单位:
DEOXYNUCLEOSIDE ANALOGS AS POTENTIAL ANTIVIRAL AGENTS
-
批准号:3144250
-
项目类别:
-
资助金额:$17.92万
-
财政年份:1990
-
负责人:TAI-SHUN LIN
-
依托单位:
3'-DEOXYNUCLEOSIDE ANALOGS AS POTENTIAL ANTIVIRAL AGENTS
-
批准号:3144249
-
项目类别:
-
资助金额:$12.19万
-
财政年份:1990
-
负责人:TAI-SHUN LIN
-
依托单位:
DEOXY NUCLEOSIDE ANALOGS AS POTENTIAL ANTIVIRAL AGENTS
-
批准号:2064982
-
项目类别:
-
资助金额:$18.49万
-
财政年份:1990
-
负责人:TAI-SHUN LIN
-
依托单位:
NOVEL NUCLEOSIDES AS ANTICANCER AND ANTIVIRAL AGENTS
-
批准号:3188511
-
项目类别:
-
资助金额:$13.68万
-
财政年份:1987
-
负责人:TAI-SHUN LIN
-
依托单位:
NOVEL NUCLEOSIDES AS ANTICANCER AND ANTIVIRAL AGENTS
-
批准号:3188507
-
项目类别:
-
资助金额:$13.97万
-
财政年份:1987
-
负责人:TAI-SHUN LIN
-
依托单位:
海外基金